Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021)

Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021)
Product Description

Vildagliptin & Metformin(50+850 mg), (50+1000 mg) Film Coated Tablets Reference Product: Eucreas® / Novartis 
Description: Vildagliptin & Metformin is a combination of 2 anti-diabetic agents indicated in the treatment of type 2 diabetes mellitus. More specifically, it is indicated:- In the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.- In combination with a sulphonylurea or insulin as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea or insulin.  Dossier Status: On-going  
Stability Studies: Zone II / Zone IVb 
Shelf life (Originator): Two (2) years (PA/Alu/PVC/Alu ) or 18 months (PCTFE/PVC/Alu) 
Batch Sizes: 100.000 tablets (commercial up to 1.000.000 tablets) 
Pack Sizes: To be defined / Originator pack: Box x 10, 30, 60, 120, 180 & 360 tablets

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
Specifications

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since

More Products from ANFARM HELLAS S.A. (36)

  • Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

    Product Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

    Pantoprazole 40 mg/Vial Powder for Solution for Injection
    Reference Product: Controloc® / Takeda
    Description: Pantoprazoleis a proton pump inhibitor indicated for the treatment of the Gastroesophageal Reflux Disease (GERD) with erosive esophagitis (EE) and in Pathological hypersecretion ...
  • Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)

    Product Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)

    Somatostatin 3mg/Vial Powder for Solution for Infusion
    Reference Product: Stilamin® / MSD Description: Somatostatin is indicated in cases of Growth Hormone Hypersecretion (ACROMEGALITY)
    Dossier Status: EU CTD Available
    Stability Studies: Zone II / Zone IVb
    Shelf life (Origi...
  • Sugammadex Inj.Sol. 100mg/ml (2 & 5 ml Vial) (EU CTD Available)

    Product Sugammadex Inj.Sol. 100mg/ml (2 & 5 ml Vial) (EU CTD Available)

    Sugammadex 100mg/ml (2 & 5 ml Vial) Solution for Injection
    Reference Product: Bridion® / MSD
    Description: Sugammadex is a modified gamma cyclodextrin which is a Selective Relaxant Binding Agent. 
    It forms a complex with the neuromuscular blocking agents rocuronium or vecuronium in plasma ...
  • Tenoxicam Ps.Inj.Sol 20mg/Vial (EU CTD Available)

    Product Tenoxicam Ps.Inj.Sol 20mg/Vial (EU CTD Available)

    Tenoxicam 20 mg/Vial Powder for Solution for Injection Reference Product: Tilcitin® / Meda 
    Description:  Tenoxicam is used in patients considered unable to take oral tenoxicam for the relief of pain and inflammation in osteoarthritis and rheumatoid arthritis and for the short-term manage...
  • Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available)

    Product Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available)

    Tigecycline 50 mg/Vial Powder for Solution for Infusion Reference Product: Tygacil® / Pfizer
    Description: Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunitand blocking entry of amino-acyl tRNA molecules into the A site of the...
  • Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)

    Product Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)

    Vancomycin Vial Powder for Solution for Infusion
    Reference Product: Voncon® / Lilly
    Description: Vancomycin Hydrochloride is a glycopeptide antibacterial indicated in adult and pediatric patients (neonates and older) for the treatment of Septicemia, Infective Endocarditis, Ski...
  • Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

    Product Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

    Voriconazole 200 mg/Vial Powder for Solution for Infusion
    Reference Product: Vfend® / Pfizer
    Description: In the treatment of the following fungal infections: Invasive aspergillosis, Candidemia, Esophageal candidiasis, Serious fungal infections caused ...
  • Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Product Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Amikacin Solution for Injection 
    Reference Product: Briklin® / BRISTOL-MYERS SQUIBB
    Description: Amikacin sulfate is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species,&nb...
  • Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab  (under development)

    Product Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

    Apixaban Film Coated Tablets 2.5mg & 5mg
    Reference Product: Eliquis® / Bristol-Myers Squibb/Pfizer
    Description: Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transie...
  • Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Product Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Azithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Zithromax® / PFIZER 
    Description: Azithromycin as powder for solution for infusion is indicated for the treatment of community-acquired pneumonia due to susceptible microorganisms in adult patients where initial intrav...
  • Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Product Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Brivaracetam 10mg/ml Oral Solution
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and children from 4 year...
  • Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Product Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and...

ANFARM HELLAS S.A. resources (2)